Cargando…

Cisplatin and its analogues in the treatment of advanced breast cancer: a review.

Detalles Bibliográficos
Autores principales:	Smith, I. E., Talbot, D. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977765/ https://www.ncbi.nlm.nih.gov/pubmed/1616849

Ejemplares similares

Effects of Cisplatin and its Analogues on the Permeability of Human Erythrocyte Membrane
por: Lu, J.-F., et al.
Publicado: (1995)

A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer.
por: Ellis, P. A., et al.
Publicado: (1995)

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
por: Ellis, P. A., et al.
Publicado: (1995)

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors
por: Koczywas, M, et al.
Publicado: (2014)

Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
por: Takekuma, Munetaka, et al.
Publicado: (2015)

LHRH analogues in breast cancer: clever, but do we need them?
por: Smith, I. E.
Publicado: (1991)

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
por: O'Byrne, K J, et al.
Publicado: (1999)

Effect of Cisplatin and Its Cationic Analogues in the Phase Behavior and Permeability of Model Lipid Bilayers
por: Martinho, Nuno, et al.
Publicado: (2023)

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer
por: Urruticoechea, A, et al.
Publicado: (2005)

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
por: MacNeill, F. A., et al.
Publicado: (1992)

Cisplatin in breast cancer.
por: Willemse, P., et al.
Publicado: (1993)

Advantages in Combination Chemotherapy Using Cisplatin and Its Analogues for Human Testicular Tumor Xenografts
por: Hida, Shuichi, et al.
Publicado: (1990)

The potential role of somatostatin analogues in breast cancer treatment.
por: Pollak, M.
Publicado: (1997)

LHRH analogues and breast cancer.
por: Korkut, E., et al.
Publicado: (1991)

Determining sensitivity to rapamycin and its analogues in breast cancer patients
por: Witton, Caroline J
Publicado: (2005)

Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy.
por: Fosså, S. D., et al.
Publicado: (1996)

Treatment of Advanced or Recurrent Cervical Cancer with Cisplatin or Cisplatin Containing Regimens: A Cost Effective Analysis
por: Geisler, John P., et al.
Publicado: (2012)

Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature
por: Reynaert, Hendrik, et al.
Publicado: (2019)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
por: Athanassiou, A. E., et al.
Publicado: (1989)

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
por: Fiteni, Frédéric, et al.
Publicado: (2014)

Recent advances in the synthesis of biologically and pharmaceutically active quinoline and its analogues: a review
por: Weyesa, Abdanne, et al.
Publicado: (2020)

Recent advances in the synthesis of pharmaceutically active 4-quinolone and its analogues: a review
por: Dine, Ilili, et al.
Publicado: (2023)

New Advancements in Cisplatin-Based Treatments
por: Gentilin, Erica
Publicado: (2023)

Cisplatin or Not in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2013)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.
por: Gulliford, T., et al.
Publicado: (1998)

The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer
por: Wu, Weilu, et al.
Publicado: (2023)

Autophagy induced by a sulphamoylated estrone analogue contributes to its cytotoxic effect on breast cancer cells
por: Verwey, Marcel, et al.
Publicado: (2016)

Asthma and Its Analogues
por: Illingworth, C. R.
Publicado: (1893)

Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
por: Telli, Melinda L., et al.
Publicado: (2022)

Thalidomide and its analogues in the treatment of Multiple Myeloma
por: Latif, Tahir, et al.
Publicado: (2012)

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
por: Raderer, M, et al.
Publicado: (1999)

Novel Metformin Analogues for Treatment of Pancreatic Cancer
por: Burton, Lorena P, et al.
Publicado: (2021)

Clinical efficacy of weekly cisplatin for treatment of patients with breast cancer
por: Ma, Ying, et al.
Publicado: (2019)

Review of Insulin and its Analogues in Diabetes Mellitus
por: Mane, Krishnappa, et al.
Publicado: (2012)

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
por: Hardy, J. R., et al.
Publicado: (1989)

Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis
por: Zhu, Jiahao, et al.
Publicado: (2018)

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence
por: Bronsveld, Heleen K, et al.
Publicado: (2015)

Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
por: Ozkaya, Sevket, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_lcvd6a975r9t3o7snmfbee74n3